nach oben

Erschienen in:

23.01.2019 | Letter to the Editor

Pegfilgrastim in primary prophylaxis of febrile neutropenia in elderly patients with hematological malignancies—bendamustine and G-CSF support

verfasst von: Claudio Cerchione, Amalia De Renzo, Davide Nappi, Maria Di Perna, Roberta Della Pepa, Novella Pugliese, Lucio Catalano, Fabrizio Pane, Marco Picardi

Erschienen in: Supportive Care in Cancer | Ausgabe 5/2019

Einloggen, um Zugang zu erhalten

Excerpt

Dear editor, …

Imataki O, Uchida S, Yokokura S, Uemura M, Kadowaki N (2018) Bendamustine and G-CSF support. Support Care Cancer

Cerchione C, De Renzo A, Di Perna M et al (2017) Pegfilgrastim in primary prophylaxis of febrile neutropenia following frontline bendamustine plus rituximab treatment in patients with indolent non-Hodgkin lymphoma: a single center, real-life experience. Support Care Cancer 25(3):839–845CrossRefPubMed

Balducci L, Repetto L (2004) Increased risk of myelotoxicity in elderly patients with non-Hodgkin lymphoma. Cancer 100(1):6–11CrossRef

Sosa R, Li S, Molony JT, Liu J, Stryker S, Collins AJ (2017) Use of prophylactic growth factors and antimicrobials in elderly patients with cancer: a review of the Medicare database. Support Care Cancer 25(10):3123–3132CrossRefPubMed

Mondello P, Steiner N, Willenbacher W, Cerchione C, Nappi D, Mauro E, Ferrero S, Cuzzocrea S, Mian M (2018) Bendamustine plus rituximab versus R-CHOP as first-line treatment for patients with follicular lymphoma grade 3A: evidence from a multicenter, retrospective study. Oncologist 23(4):454–460CrossRefPubMedPubMedCentral

Cerchione C, Catalano L, Pareto AE et al (2017) Pegfilgrastim in primary prophylaxis of febrile neutropenia during chemotherapy of relapsed and refractory multiple myeloma: a real-life experience. Support Care Cancer 23(2):301–302CrossRef

Cerchione C, Catalano L, Peluso I, Nappi D, di Perna M, Salvatore D, Migliaccio I, Picardi M, Pane F (2016) Managing neutropenia by pegfilgrastim in patients affected by relapsed/refractory multiple myeloma treated with bendamustine-bortezomib-dexamethasone. Support Care Cancer 24(12):4835–4837CrossRefPubMedPubMedCentral

Cerchione C, Nappi D, Di Perna M et al (2017) A case of efficacy of bendamustine in heavily pretreated multiple myeloma, refractory to pomalidomide. Clin Case Rep 5(4):505–507CrossRefPubMedPubMedCentral

Cerchione C, Nappi D, Di Perna M et al (2016) Retreatment with bendamustine-bortezomib-dexamethasone in a patient with relapsed/refractory multiple myeloma. Case Rep Hematol 2016:6745286PubMedPubMedCentral

Titel: Pegfilgrastim in primary prophylaxis of febrile neutropenia in elderly patients with hematological malignancies—bendamustine and G-CSF support
verfasst von: Claudio Cerchione
Amalia De Renzo
Davide Nappi
Maria Di Perna
Roberta Della Pepa
Novella Pugliese
Lucio Catalano
Fabrizio Pane
Marco Picardi
Publikationsdatum: 23.01.2019
Verlag: Springer Berlin Heidelberg
Erschienen in: Supportive Care in Cancer / Ausgabe 5/2019
Print ISSN: 0941-4355
Elektronische ISSN: 1433-7339
DOI: https://doi.org/10.1007/s00520-019-4651-5

Neu im Fachgebiet Onkologie

24.04.2024 | DGIM 2024 | Nachrichten

Springer Medizin

Pegfilgrastim in primary prophylaxis of febrile neutropenia in elderly patients with hematological malignancies—bendamustine and G-CSF support

Excerpt

Neu im Fachgebiet Onkologie

Bei Senioren mit Prostatakarzinom auf Anämie achten!

ICI-Therapie in der Schwangerschaft wird gut toleriert

Krebspatienten impfen: Was? Wen? Und wann nicht?

Müde im Alter? Auch an die Nebenniere denken

Update Onkologie

Springer Medizin

Excerpt

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 5/2019

The influence of partner involvement in the decision-making process on body image and decision regret among women receiving breast reconstruction

“It still affects our economic situation”: long-term economic burden of breast cancer and lymphedema

Reimagine: a randomized controlled trial of an online, symptom self-management curriculum among breast cancer survivors

Reply to: Prevalence, characteristics, and treatment of fatigue in oncological cancer patients in Italy: a cross-sectional study of the Italian Network for Supportive Care in Cancer (NICSO)

Developing innovative models of care for cancer survivors: use of implementation science to guide evaluation of appropriateness and feasibility

Development of Measure Yourself Concerns and Wellbeing for informal caregivers of people with cancer—a multicentred study

Neu im Fachgebiet Onkologie

Bei Senioren mit Prostatakarzinom auf Anämie achten!

ICI-Therapie in der Schwangerschaft wird gut toleriert

Krebspatienten impfen: Was? Wen? Und wann nicht?

Müde im Alter? Auch an die Nebenniere denken

Update Onkologie